Your browser doesn't support javascript.
loading
Cancer immunometabolism: advent, challenges, and perspective.
Dang, Qin; Li, Borui; Jin, Bing; Ye, Zeng; Lou, Xin; Wang, Ting; Wang, Yan; Pan, Xuan; Hu, Qiangsheng; Li, Zheng; Ji, Shunrong; Zhou, Chenjie; Yu, Xianjun; Qin, Yi; Xu, Xiaowu.
Affiliation
  • Dang Q; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Jin B; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Ye Z; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Lou X; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang T; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang Y; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Pan X; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Hu Q; School of Clinical Medicine, Zhengzhou University, Zhengzhou, China.
  • Li Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Ji S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhou C; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Yu X; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Qin Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Mol Cancer ; 23(1): 72, 2024 Apr 05.
Article de En | MEDLINE | ID: mdl-38581001
ABSTRACT
For decades, great strides have been made in the field of immunometabolism. A plethora of evidence ranging from basic mechanisms to clinical transformation has gradually embarked on immunometabolism to the center stage of innate and adaptive immunomodulation. Given this, we focus on changes in immunometabolism, a converging series of biochemical events that alters immune cell function, propose the immune roles played by diversified metabolic derivatives and enzymes, emphasize the key metabolism-related checkpoints in distinct immune cell types, and discuss the ongoing and upcoming realities of clinical treatment. It is expected that future research will reduce the current limitations of immunotherapy and provide a positive hand in immune responses to exert a broader therapeutic role.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunité / Tumeurs Limites: Humans Langue: En Journal: Mol Cancer Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunité / Tumeurs Limites: Humans Langue: En Journal: Mol Cancer Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays d'affiliation: Chine
...